L Mosekilde

2.6k total citations · 1 hit paper
46 papers, 1.9k citations indexed

About

L Mosekilde is a scholar working on Nephrology, Orthopedics and Sports Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, L Mosekilde has authored 46 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Nephrology, 19 papers in Orthopedics and Sports Medicine and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in L Mosekilde's work include Bone health and osteoporosis research (19 papers), Parathyroid Disorders and Treatments (16 papers) and Bone health and treatments (10 papers). L Mosekilde is often cited by papers focused on Bone health and osteoporosis research (19 papers), Parathyroid Disorders and Treatments (16 papers) and Bone health and treatments (10 papers). L Mosekilde collaborates with scholars based in Denmark, Germany and United States. L Mosekilde's co-authors include Lars Rejnmark, Moustapha Kassem, Pia Eiken, Jens‐Erik Beck Jensen, Erik Fink Eriksen, Lis Stilgren, Charlotte Landbo Tofteng, Louise Lind Schierbeck, Lars Køber and Peter Vestergaard and has published in prestigious journals such as Endocrinology, BMJ and Journal of Bone and Mineral Research.

In The Last Decade

L Mosekilde

46 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial

2012 473 citations Louise Lind Schierbeck, Lars Rejnmark et al. BMJ profile →

Peers

Countries citing papers authored by L Mosekilde

Since Specialization

Citations

This map shows the geographic impact of L Mosekilde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Mosekilde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Mosekilde more than expected).

Fields of papers citing papers by L Mosekilde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Mosekilde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Mosekilde. The network helps show where L Mosekilde may publish in the future.

Co-authorship network of co-authors of L Mosekilde

This figure shows the co-authorship network connecting the top 25 collaborators of L Mosekilde. A scholar is included among the top collaborators of L Mosekilde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Mosekilde. L Mosekilde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Maternal and infant vitamin D status during the first 9 months of infant life—a cohort study 2013 ·European Journal of Clinical Nutrition ·Súsanna vid Streym, Ulla Møller, Lars Rejnmark, Lene Heickendorff, L Mosekilde, Peter Vestergaard	67
2	Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial breakdown → 2012 ·BMJ ·Louise Lind Schierbeck, Lars Rejnmark, Charlotte Landbo Tofteng, Lis Stilgren, Pia Eiken, L Mosekilde, Lars Køber, Jens‐Erik Beck Jensen	473
3	Plasma 1,25‐dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function 2006 ·Clinical Endocrinology ·(unknown), Peter Vestergaard, Lene Heickendorff, L Mosekilde	23
4	Skeletal growth and long‐term bone turnover after enterocystoplasty in a chronic rat model 2003 ·British Journal of Urology ·Elmar W. Gerharz, Jürg A. Gasser, L Mosekilde, Caje Moniz, H. Sitter, (unknown), Jesper Skovhus Thomsen, P.G. Ransley, H. Riedmiller, Christopher R.J. Woodhouse	8
5	Dose‐effect relations of loop‐ and thiazide‐diuretics on calcium homeostasis: a randomized, double‐blinded Latin‐square multiple cross‐over study in postmenopausal osteopenic women 2003 ·European Journal of Clinical Investigation ·Lars Rejnmark, Peter Vestergaard, Asger Roer Pedersen, Lene Heickendorff, F. Andreasen, L Mosekilde	58
6	Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women — results of the Danish Osteoporosis Prevention Study 2000 ·Maturitas ·L Mosekilde, Henning Beck‐Nielsen, Ole Helmer Sørensen, S. Pors Nielsen, Peder Charles, Peter Vestergaard, Anne Pernille Hermann, Jeppe Gram, Tony Bill Hansen, Bo Abrahamsen, E.N. Ebbesen, Lis Stilgren, Lars Bjørn Jensen, Christine Brot, Birgitte Hansen, Charlotte Landbo Tofteng, Pia Eiken, Niels Kolthoff	108
7	Artifact in Bone Mineral Measurements During a Very Low Calorie Diet 2000 ·Journal of Clinical Densitometry ·(unknown), Jens Børglum, Lene Heickendorff, L Mosekilde, Bjørn Richelsen	12
8	Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis) 1999 ·Bone ·C. P. Jerome, (unknown), (unknown), (unknown), Jeannie F. Bailey, (unknown), F. Clarke Fraser, Lisa Hansen, (unknown), Melanie K. Shadoan, C. J. Lees, Jesper Skovhus Thomsen, L Mosekilde	64
9	Analysis of the effects of growth hormone, voluntary exercise, and food restriction on diaphyseal bone in female F344 rats 1999 ·Bone ·(unknown), P. B. Orhii, Wilson Mejía, Roger McCarter, L Mosekilde, Jesper Skovhus Thomsen, Dike N. Kalu	54
10	Effects of growth hormone treatment on serum levels of insulin‐like growth factors (IGFs) and IGF binding proteins 1–4 in postmenopausal women 1998 ·Clinical Endocrinology ·Moustapha Kassem, Kim Brixen, L Mosekilde, Werner Blum, Allan Flyvbjerg	17
11	Bone mass, bone turnover and body composition in former hypothyroid patients receiving replacement therapy 1996 ·European Journal of Endocrinology ·Bente Langdahl, Anne Gitte Loft, Erik Fink Eriksen, L Mosekilde, Peder Charles	31
12	No evidence for reduced spontaneous or growth-hormone-stimulated serum levels of insulin-like growth factor (IGF)-I, IGF-II or IGF binding protein 3 in women with spinal osteoporosis 1994 ·European Journal of Endocrinology ·Moustapha Kassem, Kim Brixen, Werner Blum, L Mosekilde, E.F. Eriksen	34
13	Familial isolated primary hyperparathyroidism 1994 ·Clinical Endocrinology ·Moustapha Kassem, (unknown), (unknown), (unknown), L Mosekilde, Torben A. Kruse	35
14	Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro 1993 ·Calcified Tissue International ·Moustapha Kassem, Werner Blum, (unknown), L Mosekilde, Erik Fink Eriksen	178
15	Effects of intravenous EDTA treatment on serum parathyroid hormone (1-84) and biochemical markers of bone turnover. 1993 ·PubMed ·B Guldager, (unknown), (unknown), H.K. Nielsen, L Mosekilde, R Jelnes	13
16	Primary hyperparathyroidism: Iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods 1992 ·Bone ·Peer Christiansen, Torben Steiniche, A. Vesterby, L Mosekilde, I Hessov, F. Melsen	114
17	Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment 1991 ·Critical Reviews in Oncology/Hematology ·L Mosekilde, Erik Fink Eriksen, Peder Charles	13
18	Evidence for a long-term storage of calcitriol in a patient with 1-alpha hydroxylase deficiency and rickets 1990 ·European Journal of Endocrinology ·Jørgen Rungby, L Mosekilde, Jørgen Poulsen	1
19	[Hormonal regulation of bone remodeling]. 1989 ·PubMed ·Erik Fink Eriksen, F. Melsen, L Mosekilde	1
20	[Treatment with sodium fluoride, calcium phosphate and vitamin D2 in spinal osteoporosis. Effect on calcium balance, calcium metabolism, bone remodelling, and side effects]. 1986 ·PubMed ·L Mosekilde, P. Charles, (unknown), C. Hasling, F. Melsen	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact